Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
111C-methionine PET/CT1件: Methionine C-11---1件: 75 💬
211C-UCB-J PET-CT----1件: 8 💬
313nh3 PET/CT scan----1件: 84 💬
418F-dopa PET----1件: 6 💬
518F-FDG and 68GA-fapi PET/CT1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 96 💬
618F-FDG PET-MR1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 8 💬
718F-FDG PET/CT1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 41 💬
818F-FDG-PET/MRI1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 84 💬
918F-fgln PET imaging----1件: 86 💬
1018F-fluorodeoxyglucose (18F-FDG) PET/CT----1件: 84 💬
1118F-GE180-PET/MRI----1件: 84 💬
1218FDG PET scan----1件: 41 💬
1318FDG PET/CT scan----1件: 84 💬
145-year follow-UP DPA-714-PET/MRI----1件: 6 💬
1564CU-dotatate PET/CT scan1件: Copper oxodotreotide Cu-64---1件: 84 💬
1668-GA HA-dotatate PET/CT----1件: 41 💬
1768GA-DOTA-tate PET/MR and PET/CT imaging----1件: 238 💬
1868GA-DOTA-TOC PET/CT----1件: 84 💬
1968GA-dotatate PET/CT1件: Dotatate gallium Ga-681件: Edotreotide gallium Ga-68 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 84, 238 💬
2068GA-dotatate PET/MRI1件: Dotatate gallium Ga-681件: Edotreotide gallium Ga-68 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 19 💬
21Brain PET scan----3件: 5, 7, 127 💬
22Cellulose acetate with petrolatum1件: Microcrystalline cellulose2件: Microcrystalline cellulose ,
Rayon, purified 💬 		--2件: 35, 162 💬
23Cotton gauze with petrolatum1件: Cotton---2件: 35, 162 💬
24Dotatate PET-CT1件: Dotatate---1件: 75 💬
25DPA-714 PET/MRI----1件: 13 💬
26Entire-body PET-CT scans----1件: 13 💬
27ESR-specific PET scan----1件: 86 💬
28F-dopa PET CT----1件: 75 💬
29FDG PET scan----2件: 6, 85 💬
30FDG-PET----3件: 5, 6, 7 💬
31FDG-PET/CT with RB82 myocardial perfusion imaging----1件: 84 💬
32GE180 PET scan----1件: 6 💬
33H215O PET----2件: 6, 17 💬
34MRI, FDG-PET/CT scans----1件: 34 💬
35PET (positron emission tomography) study----1件: 17 💬
36PET imaging----1件: 85 💬
37PET with 11C-flumazenil----1件: 13 💬
38PET with [11C]flumazenil----1件: 13 💬
39PET-CT----1件: 40 💬
40PET-CT imaging with [89ZR]-bevacizumab----1件: 86 💬
41PET/CT----4件: 5, 6, 7, 127 💬
42PET/CT scan----2件: 13, 67 💬
43PET/CT scan: TWO PET scans using 1. C-11 HED and 2. N-13 ammonia or rubidium-82----1件: 86 💬
44PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----1件: 85 💬
45PET/MR with [11C]PBR28----1件: 6 💬
46PET10----1件: 41 💬
47PET3----1件: 41 💬
48Pethidine1件: Meperidine (Petydyna)2件: Meperidine hydrochloride (Pethidine hydrochloride),
Pethidine (Pethidine, Pethidine DBL) 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 97, 298 💬
49Petrolatum1件: Petrolatum (Petrolatum)2件: Petrolatum, white (Petrolatum, white, White petrolatum),
Petrolatum (Petrolatum, Yellow petrolatum) 💬 		--1件: 158 💬
50Rubidium PET1件: Rubidium---1件: 84 💬
51Simultaneous combined 18F-FDG PET and cardiac MRI imaging----1件: 84 💬
52Stress myocardial perfusion PET----1件: 46 💬